Endotoxin Testing Market New Trends, Growth Opportunities, Top Players And Forecast To 2033

The endotoxin testing market size has grown steadily in recent years. It will grow from $2.14 billion in 2023 to $2.24 billion in 2024 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to increasing demand for biologics and biosimilars, growing awareness about the importance of endotoxin testing, growing prevalence of infectious diseases.

The endotoxin testing market size is expected to see strong growth in the next few years. It will grow to $2.73 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to expansion of the biopharmaceutical industry, increasing investment in research and development of endotoxin testing, global healthcare expansion. Major trends in the forecast period include innovative endotoxin detection tools, adoption of endotoxin testing service, demand for endotoxin testing services.

Market Overview -
Endotoxin testing, or the bacterial endotoxins test (BET), refers to an in vitro assay that involves assessing bacterial endotoxin levels in substances, particularly pharmaceuticals and medical devices, to ensure product safety and compliance with quality standards. This testing helps prevent potential adverse effects on patients and users.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=12932&type=smp

Rising Healthcare-Associated Infections Fuel Growth In The Endotoxin Testing Market
The increasing number of healthcare-associated infections is expected to propel the growth of the endotoxin testing market going forward. Healthcare-associated infections refer to infections acquired while receiving medical care that were not present at the time of admission to the hospital. Healthcare-associated infections often arise from contaminated medical equipment or procedures, necessitating rigorous testing to ensure patient safety. Endotoxin testing services significantly prevent healthcare-associated infections by assessing the bacterial endotoxin levels in medical equipment, especially injectable pharmaceutical products and implantable medical devices. For instance, in December 2022, according to the United Nations International Children's Emergency Fund (UNICEF), a US-based agency of the United Nations, pneumonia was the infectious disease that killed the most children, taking the lives of over 700,000 of them annually, or around 2,000 per day. Furthermore, in May 2022, according to the World Health Organization, a Switzerland-based agency of the United Nations, 24% of patients are affected by healthcare-associated sepsis every year and 52.3% of those patients treated in an intensive care unit die each year. Therefore, the increasing number of healthcare-associated infections is driving the growth of the endotoxin testing market.

Competitive Landscape -
Major players in the endotoxin testing market are Thermo Fisher Scientific Inc., Merck KGaA, bioMérieux SA., Eurofins Scientific SE, Lonza Group Ltd., WuXi AppTec Co. Ltd., Bio-Rad Laboratories Inc., Maravai LifeSciences Holdings Inc., Cambrex Corporation, GenScript Biotech Corporation, Charles River Laboratories International Inc., Nelson Laboratories LLC, Lifecore Biomedical Inc., Stellar Biotechnologies Inc., Biovision Inc., Associates of Cape Cod Inc., FUJIFILM Wako Pure Chemical Corporation, InvivoGen Inc., Tebu-bio Nv., MatTek Corporation, Microcoat Biotechnologie GmbH, Accelagen Inc., BioAssay Systems LLC, BioThema AB, Hycult Biotech Inc., Pacific Biolabs Inc., Xiamen Bioendo Technology Co. Ltd., Zhanjiang A&C Biological Ltd., Accugen Laboratories Inc.

Cutting-Edge Technology Reshapes The Landscape Of Endotoxin Testing Market
Major companies operating in the endotoxin testing market are focused on adopting new technological solutions to sustain their position in the market. For instance, in August 2023, Lonza Group AG, a Switzerland-based pharmaceutical, biotechnology and nutrition manufacturing company, launched the Nebula absorbance reader, a new absorbance microplate reader for streamlined endotoxin and pyrogen testing. The instrument is fully connected with Lonza's most recent WinKQCL software to facilitate data integrity compliance, speed training and lessen validation load. There is no longer a requirement for WinKQCL software users to learn new software to utilize the contemporary reader, reducing training demands. The Nebula Absorbance Reader is an innovative and technologically advanced replacement reader that produces outcomes similar to those frequently observed with the ELx808, the industry-standard absorbance reader that Lorenz no longer offers for sale. Additionally, it is designed to be compatible with and adhere to the exacting requirements of Lonza's absorbance-based endotoxin assays, including the Lonza PYROGENT 5000 Turbidimetric and Kinetic-QCL Chromogenic Endotoxin Assays.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/endotoxin-testing-global-market-report

Key Segments -
The endotoxin testing market covered in this report is segmented -
1) By Test Type: LAL (Limulus Amebocyte Lysate) Test; Chromogenic Tests; Turbidimetric Tests; Gel Clot Tests; MAT Test; Rabbit Pyrogen Test; Recombinant Factor C (rFC) Assay
2) By Application: Medical Devices; Pharmaceuticals; Packaging; Raw Materials
3) By End-User: Hospitals; Laboratories; Research Institutes

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.